371 related articles for article (PubMed ID: 17991769)
1. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
Le Vee M; Gripon P; Stieger B; Fardel O
Drug Metab Dispos; 2008 Feb; 36(2):217-22. PubMed ID: 17991769
[TBL] [Abstract][Full Text] [Related]
2. Regulation of drug transporter expression by oncostatin M in human hepatocytes.
Le Vee M; Jouan E; Stieger B; Lecureur V; Fardel O
Biochem Pharmacol; 2011 Aug; 82(3):304-11. PubMed ID: 21570956
[TBL] [Abstract][Full Text] [Related]
3. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.
Le Vee M; Lecureur V; Stieger B; Fardel O
Drug Metab Dispos; 2009 Mar; 37(3):685-93. PubMed ID: 19074973
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes.
Le Vee M; Lecureur V; Moreau A; Stieger B; Fardel O
Drug Metab Dispos; 2009 Nov; 37(11):2228-35. PubMed ID: 19661216
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line.
Le Vee M; Jigorel E; Glaise D; Gripon P; Guguen-Guillouzo C; Fardel O
Eur J Pharm Sci; 2006 May; 28(1-2):109-17. PubMed ID: 16488578
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia.
Hartmann G; Cheung AK; Piquette-Miller M
J Pharmacol Exp Ther; 2002 Oct; 303(1):273-81. PubMed ID: 12235261
[TBL] [Abstract][Full Text] [Related]
7. Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes.
Le Vee M; Jouan E; Moreau A; Fardel O
Fundam Clin Pharmacol; 2011 Feb; 25(1):99-103. PubMed ID: 20199580
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.
Geier A; Dietrich CG; Voigt S; Ananthanarayanan M; Lammert F; Schmitz A; Trauner M; Wasmuth HE; Boraschi D; Balasubramaniyan N; Suchy FJ; Matern S; Gartung C
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G831-41. PubMed ID: 15860642
[TBL] [Abstract][Full Text] [Related]
9. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
[TBL] [Abstract][Full Text] [Related]
10. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
[TBL] [Abstract][Full Text] [Related]
11. Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells.
Le Vee M; Noel G; Jouan E; Stieger B; Fardel O
Toxicol In Vitro; 2013 Sep; 27(6):1979-86. PubMed ID: 23850984
[TBL] [Abstract][Full Text] [Related]
12. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines.
Fardel O; Le Vée M
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1469-81. PubMed ID: 19785515
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients.
Nakai K; Tanaka H; Hanada K; Ogata H; Suzuki F; Kumada H; Miyajima A; Ishida S; Sunouchi M; Habano W; Kamikawa Y; Kubota K; Kita J; Ozawa S; Ohno Y
Drug Metab Dispos; 2008 Sep; 36(9):1786-93. PubMed ID: 18515332
[TBL] [Abstract][Full Text] [Related]
15. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
Gartung C; Matern S
Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
[TBL] [Abstract][Full Text] [Related]
16. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.
Le Vee M; Jouan E; Stieger B; Lecureur V; Fardel O
PLoS One; 2015; 10(3):e0121232. PubMed ID: 25803276
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
19. Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells.
Kullak-Ublick GA; Beuers U; Paumgartner G
Hepatology; 1996 May; 23(5):1053-60. PubMed ID: 8621133
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia.
Chen HL; Liu YJ; Chen HL; Wu SH; Ni YH; Ho MC; Lai HS; Hsu WM; Hsu HY; Tseng HC; Jeng YM; Chang MH
Pediatr Res; 2008 Jun; 63(6):667-73. PubMed ID: 18327154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
